title: Composite end points, black box warnings, and allegations of bias.
authors.forename: John
authors.initials: J
authors.lastname: Somberg
mesh_terms: D002986:Clinical Trials as Topic / Q000379:methods* / Q000592:standards; D000077144:Clopidogrel; D004345:Drug Industry / Q000592:standards; D004348:Drug Labeling / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D023381:Endpoint Determination; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D013988:Ticlopidine / Q000009:adverse effects / Q000031:analogs & derivatives / Q000494:pharmacology
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine